<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>116</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Meningococcal B</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Meningococcal B vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>118</observationCode>
<observationTitle>Severe allergic reaction to tetanus toxoid</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to tetanus toxoid.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>Meningococcal B risk 2-dose series MenB-4C Patient Seeks Protection</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Patient Seeks Protection</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>16 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>ACIP recommends a MenB vaccine series for persons aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years.</guidance>
</indication>
<indication>
<observationCode>
<text>Patient seeks Meningococcal B protection</text>
<code>177</code>
</observationCode>
<description>Administer to persons seeking protection from Meningococcal B.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>ACIP recommends a MenB vaccine series for persons aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years.</guidance>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>16 years</minAge>
<earliestRecAge>16 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>16 years</minAge>
<earliestRecAge>16 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate>20170518</cessationDate>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate>20170519</effectiveDate>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Meningococcal B risk 2-dose series MenB-FHbp</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance>A 2-dose series for MenB-FHbp (Trumenba) which is used only for healthy adolescents and young adults who are not at increased risk for meningococcal B disease.</seriesAdminGuidance>
<seriesAdminGuidance>Penbraya (MenABCWY - Pfizer) may be used when both MenACWY and MenB are indicated at the same visit.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Patient Seeks Protection</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>16 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Patient seeks protection</text>
<code>001</code>
</observationCode>
<description>Administer to persons seeking protection.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>ACIP recommends a MenB vaccine series for persons aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years.</guidance>
</indication>
<indication>
<observationCode>
<text>Patient seeks Meningococcal B protection</text>
<code>177</code>
</observationCode>
<description>Administer to persons seeking protection from Meningococcal B.</description>
<beginAge>16 years</beginAge>
<endAge>24 years</endAge>
<guidance>ACIP recommends a MenB vaccine series for persons aged 16-23 years on the basis of shared clinical decision-making to provide short-term protection against most strains of serogroup B meningococcal disease. The preferred age for MenB vaccination is 16-18 years.</guidance>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>16 years</minAge>
<earliestRecAge>16 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years</beginAge>
<endAge>26 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>16 years</minAge>
<earliestRecAge>16 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>6 months - 4 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Meningococcal B risk 2-dose series MenB-4C Increased Risk</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>10 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Undergoing elective splenectomy</text>
<code>002</code>
</observationCode>
<description>Administered to persons who are undergoing elective splenectomy if they have not previously received Meningococcal B vaccine. </description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance>Vaccination 14 or more days before splenectomy is suggested.</guidance>
</indication>
<indication>
<observationCode>
<text>Microbiologists routinely exposed to Neisseria meningitidis</text>
<code>050</code>
</observationCode>
<description>Administer to microbiologists routinely exposed to isolates of Neisseria meningitidis.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persons at risk during an outbreak</text>
<code>070</code>
</observationCode>
<description>Administer to persons identified as at increased risk because of a serogroup B meningococcal disease outbreak</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, including inherited or chronic deficiencies in C3, C5-9, properdin, factor D, factor H, or who are taking eculizumab (Soliris).</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>10 years</minAge>
<earliestRecAge>10 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate>20170518</cessationDate>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate>20170519</effectiveDate>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Bexsero</tradeName>
<mvx>NOV</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>1 years - 4 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>2 years - 4 days</absMinInt>
<minInt>2 years</minInt>
<earliestRecInt>2 years</earliestRecInt>
<latestRecInt>4 years</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, OMV</vaccineType>
<cvx>163</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>Yes</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Meningococcal B risk 3-dose series MenB-FHbp Increased Risk</seriesName>
<targetDisease>Meningococcal B</targetDisease>
<vaccineGroup>Meningococcal B</vaccineGroup>
<seriesAdminGuidance>Penbraya (MenABCWY - Pfizer) may be used when both MenACWY and MenB are indicated at the same visit.</seriesAdminGuidance>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>Yes</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference/>
<minAgeToStart>10 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Undergoing elective splenectomy</text>
<code>002</code>
</observationCode>
<description>Administered to persons who are undergoing elective splenectomy if they have not previously received Meningococcal B vaccine. </description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance>Vaccination 14 or more days before splenectomy is suggested.</guidance>
</indication>
<indication>
<observationCode>
<text>Microbiologists routinely exposed to Neisseria meningitidis</text>
<code>050</code>
</observationCode>
<description>Administer to microbiologists routinely exposed to isolates of Neisseria meningitidis.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persons at risk during an outbreak</text>
<code>070</code>
</observationCode>
<description>Administer to persons identified as at increased risk because of a serogroup B meningococcal disease outbreak</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons 10 years or older with persistent complement component deficiencies, including inherited or chronic deficiencies in C3, C5-9, properdin, factor D, factor H, or who are taking eculizumab (Soliris).</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>10 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>10 years - 4 days</absMinAge>
<minAge>10 years</minAge>
<earliestRecAge>10 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years</beginAge>
<endAge>26 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate>20170518</cessationDate>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>4 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate>20170519</effectiveDate>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Evaluation</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required once 6 months has passed since the previous dose</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Interval</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval>6 months</interval>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate>20170518</cessationDate>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 months - 4 days</absMinInt>
<minInt>4 months</minInt>
<earliestRecInt>4 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate>20170519</effectiveDate>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>6 months</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName>Trumenba</tradeName>
<mvx>PFR</mvx>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years</beginAge>
<endAge>26 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>1 years - 4 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years</beginAge>
<endAge>26 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 5</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>2 years - 4 days</absMinInt>
<minInt>2 years</minInt>
<earliestRecInt>2 years</earliestRecInt>
<latestRecInt>4 years</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<preferableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years</beginAge>
<endAge>26 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, recombinant</vaccineType>
<cvx>162</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal B, unspecified</vaccineType>
<cvx>164</cvx>
<beginAge>10 years</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF</vaccineType>
<cvx>316</cvx>
<beginAge>10 years - 4 days</beginAge>
<endAge>26 years</endAge>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>Yes</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
